RT Journal Article
SR Electronic
T1 Priority COVID-19 Vaccination for Patients with Cancer while Vaccine Supply Is Limited
JF Cancer Discovery
JO Cancer Discov
FD American Association for Cancer Research
DO 10.1158/2159-8290.CD-20-1817
A1 Ribas, Antoni
A1 Sengupta, Rajarshi
A1 Locke, Trevan
A1 Zaidi, Sayyed Kaleem
A1 Campbell, Katie M.
A1 Carethers, John M.
A1 Jaffee, Elizabeth M.
A1 Wherry, E. John
A1 Soria, Jean-Charles
A1 D'Souza, Gypsyamber
YR 2020
UL http://cancerdiscovery.aacrjournals.org/content/early/2021/01/04/2159-8290.CD-20-1817.abstract
AB Summary: Published series on COVID-19 support the notion that patients with cancer are a particularly vulner­able population. There is a confluence of risk factors between cancer and COVID-19, and cancer care and treatments increase exposure to the virus and may dampen natural immune responses. The available evidence supports the conclusion that patients with cancer, in particular with hematologic malignancies, should be considered among the very high-risk groups for priority COVID-19 vaccination.